(WEED) Roundhill Cannabis - Overview
Etf: Cannabis Cultivation, Retail, Pharmaceuticals, REITs, Ancillary
| Risk 5d forecast | |
|---|---|
| Volatility | 89.2% |
| Relative Tail Risk | -18.7% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.55 |
| Alpha | -3.10 |
| Character TTM | |
|---|---|
| Beta | 0.783 |
| Beta Downside | 1.296 |
| Drawdowns 3y | |
|---|---|
| Max DD | 81.50% |
| CAGR/Max DD | -0.17 |
Description: WEED Roundhill Cannabis December 23, 2025
The Roundhill Cannabis ETF (BATS: WEED) is an actively managed, non-diversified fund that targets exposure to the cannabis and hemp ecosystem through exchange-listed equity securities and total-return swaps. At least 80 % of its net assets are allocated to common stock, depositary receipts, or REITs that generate ≥ 50 % of revenue from, or allocate a majority of assets to, cannabis-related activities.
Key sector drivers include: (1) the U.S. adult-use market, projected to reach ≈ $30 billion in 2025 as more states legalize recreational sales; (2) a 2023-24 earnings-growth median of roughly 15 % among the top-10 holdings, reflecting expanding product lines and vertical integration; and (3) supply-chain constraints-particularly in indoor cultivation and processing capacity-that can compress margins but also create pricing power for firms with proprietary cultivation technology.
For a deeper, data-driven dive into WEED’s holdings and risk profile, you may find ValueRay’s analytical tools useful.
What is the price of WEED shares?
Over the past week, the price has changed by +3.77%, over one month by -8.99%, over three months by +4.82% and over the past year by +10.79%.
Is WEED a buy, sell or hold?
What are the forecasts/targets for the WEED price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 17.6 | -0.1% |
WEED Fundamental Data Overview February 03, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 8.03m USD (8.03m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 8.03m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 8.03m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.80% (E(8.03m)/V(8.03m) * Re(8.80%) + (debt-free company))
Discount Rate = 8.80% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)